Page last updated: 2024-08-16

troglitazone and n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea

troglitazone has been researched along with n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ban, JO; Han, SB; Hong, JT; Kang, KW; Moon, DC; Oh, JH; Son, SM; Song, HS; Song, MJ; Won, D1

Other Studies

1 other study(ies) available for troglitazone and n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea

ArticleYear
Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Cancer biology & therapy, 2011, Aug-15, Volume: 12, Issue:4

    Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; G1 Phase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoblotting; Male; Microscopy, Fluorescence; NF-kappa B; PPAR gamma; Prostatic Neoplasms; Resting Phase, Cell Cycle; RNA Interference; Thiazoles; Thiazolidinediones; Troglitazone; Urea

2011